The Impact of COVID-19 on Head and Neck Cancer Treatment: Before and During the Pandemic.

Roberto Noel SolisMehrnaz MehrzadSamya FaiqRoberto P FruscianteHarveen K SekhonMarianne AbouyaredArnaud F BewleyD Gregory FarwellAndrew C Birkeland

Published in: OTO open (2021)

Despite similar characteristics, time to diagnosis, and surgery, our findings suggest that there was an increase in primary tumor burden in patients with HNSCC during the early COVID-19 pandemic.

Keyphrases

coronavirus disease
sars cov
minimally invasive
coronary artery bypass
risk factors
combination therapy
surgical site infection